Literature DB >> 9537272

Direct and indirect costs of the acute form of lymphatic filariasis to households in rural areas of Tamil Nadu, south India.

K D Ramaiah1, K Ramu, H Guyatt, K N Kumar, S P Pani.   

Abstract

This study examined the direct and indirect costs due to acute form of lymphatic filariasis caused by Wuchereria bancrofti to the households in rural communities in Tamil Nadu state in south India. For nearly one-third of the acute adenolymphangitis (ADL) episodes the affected did not seek treatment and for 27% of the episodes they consulted health personnel, underwent treatment and paid for it. On average, the ADL patients spent Rupees (Rs.) 2.35 (US $ 0.07) per episode on treatment, but expenditure was as high as Rs. 32.11 (US $ 0.92) among those who paid. Doctor's fees and medicines constituted 83% of the total treatment costs. Patients with multiple and longer duration episodes and with better living conditions spent relatively more on treatment. The proportion of patients who spent money on treatment was smaller in poorer households, but their treatment costs formed a relatively higher proportion of their income than those of middle and high-income households. The ADL episodes curtailed economic and domestic activities. In 87% of the episodes, the affected were not able to attend any economic activity compared to 37% of the episodes in the case of controls. Patients spent only 0.68 +/- 1.91 hours on economic activity compared to 4.40 +/- 3.74 hours by the control individuals during the ADL episodes. The sign rank test showed that the mean difference of 3.73 +/- 3.81 and 2.14 +/- 1.83 hours in the time spent on economic and domestic activity respectively between cases and controls was highly significant (P < 0.01). Regression analysis demonstrated that the difference in the time spent on activities is only due to ADL and no socio-economic variable had any effect on it. The cost of treatment and loss in economic activities combined with high incidence in the study communities indicate the extent of the economic burden imposed by the hitherto neglected acute form of lymphatic filariasis and the necessity to control it.

Entities:  

Mesh:

Year:  1998        PMID: 9537272     DOI: 10.1046/j.1365-3156.1998.00208.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  20 in total

Review 1.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).

Authors:  Brian K Chu; Pamela J Hooper; Mark H Bradley; Deborah A McFarland; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

3.  Clinical and pathological aspects of filarial lymphedema and its management.

Authors:  R K Shenoy
Journal:  Korean J Parasitol       Date:  2008-09       Impact factor: 1.341

4.  Histopathologic improvement with lymphedema management, Léogâne, Haiti.

Authors:  Susan F Wilson; Jeannette Guarner; Alix L Valme; Jacky Louis-Charles; Tara L Jones; David G Addiss
Journal:  Emerg Infect Dis       Date:  2004-11       Impact factor: 6.883

5.  Current evidence on the use of antifilarial agents in the management of bancroftian filariasis.

Authors:  Sumadhya Deepika Fernando; Chaturaka Rodrigo; Senaka Rajapakse
Journal:  J Trop Med       Date:  2010-12-30

6.  A cohort study of lymphatic filariasis on socio economic conditions in Andhra Pradesh, India.

Authors:  Suryanaryana Murty Upadhyayula; Srinivasa Rao Mutheneni; Madhusudhan Rao Kadiri; Sriram Kumaraswamy; Balakrishna Nagalla
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

7.  Epidemiology of episodic adenolymphangitis: a longitudinal prospective surveillance among a rural community endemic for bancroftian filariasis in coastal Orissa, India.

Authors:  Bontha V Babu; Abhay N Nayak; Kalpataru Dhal
Journal:  BMC Public Health       Date:  2005-05-19       Impact factor: 3.295

8.  Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature.

Authors:  David G Addiss; Molly A Brady
Journal:  Filaria J       Date:  2007-02-15

9.  Clinical epidemiology of lymphatic filariasis and community practices and perceptions amongst the ado people of benue state, Nigeria.

Authors:  Edward Agbo Omudu; Jennifer Ochanya Ochoga
Journal:  Afr J Infect Dis       Date:  2011

10.  Physical disability and psychosocial impact due to chronic filarial lymphoedema in Sri Lanka.

Authors:  R S Wijesinghe; A R Wickremasinghe; Sriyani Ekanayake; M S A Perera
Journal:  Filaria J       Date:  2007-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.